Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnited Utilities Regulatory News (UU.)

Share Price Information for United Utilities (UU.)

Share Price is delayed by 15 minutes
Get Live Data
1,289.00    -16.00 (-1.23%)
Bid:
1,287.00
Ask:
1,288.00
Spread: 1.00 (0.078%)
Market Cap: £9.58b
UU. Live PriceLast checked at - London Stock Exchange

Intraday United Utilities Share Chart

Holding(s) in Company

22 Sep 2008 14:41

TR-1 (i) NOTIFICATION OF MAJOR INTERESTS IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

United Utilities Group PLC

2. Reason for the notification State Yes/No An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):

3. Full name of person(s) subject to the notification AXA S.A. 25 Avenue obligation (iii):

Matignon, 75008 Paris and its group of companies 4. Full name of shareholder(s) (if different from 3.) - (iv):

5. Date of the transaction (and date on which the 16 September 2008 threshold is crossed

or reached if different) (v): 6. Date on which issuer notified: 22 September 2008 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: -

A: Voting rights attached to shares

Class/type of Situation previous to Resulting situation after the triggering

shares the Triggering transaction (vii) if possible transaction (vi) using the ISIN CODE Number Number Number Number of voting % of voting of of of rights (ix) rights Shares Voting shares Rights (viii) Direct Direct Indirect Direct Indirect (x) (xi)

GB00B39J2M42 23,534,007 23,534,007 11,264,361 11,264,361 26,063,345 1.65% 3.82%

B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of Expiration Exercise/ Number of voting % of financial date (xiii) Conversion rights that may be voting instrument Period/ Date (xiv) acquired if the rights instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 37,327,706 5.48%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):

Name of the Company / Fund Number of Shares % of issued share capital AXA 1,361,757.00 0.19983 Direct AXA Australia 24,727.00 0.00363 Indirect AXA Colonia Konzern 1,789,651.00 0.26262 Direct AXA Colonia Konzern 63,149.00 0.00927 Indirect AXA Financial, Inc 6,136.00 0.000900435 Indirect AXA Framlington 1,822,511.00 0.27 Indirect AXA France 180,122.00 0.02643222 Indirect AXA IM UK 5,829,099.00 0.855398165 Direct AXA IM UK 931,047.00 0.136627615 Indirect AXA Rosenberg 2,029,703.00 0.297851215 Direct AXA Rosenberg 23,035,653.00 3.38039469 Indirect AXA Winterthur 254,151.00 0.037295695 Direct Total Direct 11,264,361 1.65300 Total Indirect 26,063,345 3.82470 TOTAL 37,327,706 5.47770 Proxy Voting:10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: - 12. Date on which proxy holder will cease to hold voting - rights: 13. Additional information: - 14. Contact name: Kyere Tabiri 15. Contact telephone number: 020 7003 1510

Annex Notification Of Major Interests In Shares (xvi)

A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities) AXA S.A. and its group of companies

Contact address (registered office for legal entities) 25 Avenue

Matignon, 75008 Paris Phone number Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable (xvii) Full name Kyere Tabiri Contact address 7 Newgate Street, London EC1A 7NX Phone number 020 7003 1510

Other useful information (e.g. functional relationship with AXA IM UK is a the person

100% direct

or legal entity subject to the notification obligation) subsidiary of AXA

IM S.A. which is in turn indirectly wholly owned by AXA S.A.C: Additional informationNotes

i. This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

ii. Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

iii. This should be the full name of (a) the shareholder; (b) the person acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all the parties to the agreement referred to in DTR5.2.1 (a), or (d) the direct or indirect holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, as appropriate.

In relation to the transactions referred to in points DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

- in the circumstances foreseen in DTR5.2.1 (b), the person that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

- in the circumstances foreseen in DTR 5.2.1 (c), the person holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and person lodging the collateral under these conditions;

- in the circumstances foreseen in DTR5.2.1(d), the person who has a life interest in shares if that person is entitled to exercise the voting rights attached to the shares and the person who is disposing of the voting rights when the life interest is created;

- in the circumstances foreseen in DTR5.2.1 (e), the parent undertaking and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

- in the circumstances foreseen in DTR5.2.1 (g), the person that controls the voting rights;

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

iv. Applicable in the cases provided for in DTR 5.2.1 (b) to (h). This should be the full name of the shareholder or holder of financial instruments who is the counterparty to the natural person or legal entity referred to in DTR5.2.

v. The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, date of the entering into an agreement.

The date on which threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect (see DTR 5.1.1R (3)). For passive crossings, the date when the corporate event took effect.

These dates will usually be the same unless the transaction is subject to a condition beyond the control of the parties.

vi. Please refer to the situation disclosed in the previous notification, In case the situation previous to the triggering transaction was below 3%, please state `below 3%'.

vii. If the holding has fallen below the minimum threshold , the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is less than 3%.

For the case provided for in DTR5.2.1(a), there should be no disclosure of individual holdings per party to the agreement unless a party individually crosses or reaches an Article 9 threshold. This applies upon entering into, introducing changes to or terminating an agreement.

viii. Direct and indirect

ix In case of combined holdings of shares with voting rights attached `direct holding' and voting rights `indirect holdings', please split the voting rights number and percentage into the direct and indirect columns-if there is no combined holdings, please leave the relevant box blank.

x Voting rights attached to shares in respect of which the notifying party is a direct shareholder (DTR 5.1)

xi. Voting rights held by the notifying party as an indirect shareholder (DTR 5.2.1)

xii If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

xiii date of maturity / expiration of the finical instrument i.e. the date when the right to acquire shares ends.

xiv If the financial instrument has such a period-please specify the period- for example once every three months starting from the [date]

xv. The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

xvi. This annex is only to be filed with the competent authority.

xvii. Whenever another person makes the notification on behalf of the shareholder or the natural person/legal entity referred to in DTR5.2 and DTR5.3.

mapper
Date   Source Headline
19th Jun 202612:57 pmRNSAnnual Financial Report
18th Jun 20264:31 pmRNSDirector/PDMR Shareholding
16th Jun 20262:20 pmRNSDirector/PDMR Shareholding
20th May 20264:00 pmRNSDirectorate change
12th May 20264:34 pmRNSDirector/PDMR Shareholding
7th May 20269:14 amRNSDirector/PDMR Shareholding
5th May 20265:07 pmRNSHolding(s) in Company
5th May 20264:50 pmRNSHolding(s) in Company
5th May 20263:01 pmRNSAdmission of Further Securities to Trading
1st May 20266:00 pmRNSUnited Utilities Group
1st May 20263:41 pmRNSHolding(s) in Company
30th Apr 20264:32 pmRNSResults of Placing
30th Apr 20267:00 amRNSPreliminary Results
30th Apr 20267:00 amRNSProposed Placing of New Ordinary Shares
30th Apr 20267:00 amRNSLaunch of Retail Offer
30th Apr 20267:00 amRNSStrategic Update
15th Apr 202612:13 pmRNSDirector/PDMR Shareholding
10th Apr 20262:11 pmRNSAdmission to Trading
9th Apr 20261:56 pmRNSPublication of Final Terms
27th Mar 202611:08 amRNSPublication of a Supplementary Prospectus
25th Mar 20267:00 amRNSPre-close update
23rd Mar 20263:22 pmRNSHolding(s) in Company
18th Mar 20264:26 pmRNSDirector/PDMR Shareholding
18th Mar 20262:18 pmRNSKey Corporate dates - update
13th Mar 202610:29 amRNSDirector/PDMR Shareholding
13th Mar 202610:29 amRNSDirector/PDMR Shareholding
12th Mar 202610:41 amRNSDirector/PDMR Shareholding
5th Mar 202611:19 amRNSPublication of Amended and Restated Final Terms
4th Mar 20268:57 amRNSDirector Declaration
26th Feb 202612:56 pmRNSPublication of Final Terms
25th Feb 20264:28 pmRNSDirector/PDMR Shareholding
20th Feb 202610:21 amRNSHolding(s) in Company
12th Feb 20264:15 pmRNSDirector/PDMR Shareholding
5th Feb 20262:34 pmRNSDirector/PDMR Shareholding
3rd Feb 20265:13 pmRNSDirector/PDMR Shareholding
29th Jan 20264:21 pmRNSKey corporate dates
19th Jan 20265:25 pmRNSHolding(s) in Company
14th Jan 202610:42 amRNSDirector/PDMR Shareholding
22nd Dec 20253:25 pmRNSHolding(s) in Company
22nd Dec 20253:25 pmRNSHolding(s) in Company
18th Dec 20254:42 pmRNSDirector/PDMR Shareholding
18th Dec 20254:42 pmRNSDirector/PDMR Shareholding
16th Dec 202511:28 amRNSDirector/PDMR Shareholding
8th Dec 20253:15 pmRNSDirector/PDMR Shareholding
4th Dec 20252:28 pmRNSPublication of Final Terms
2nd Dec 20254:41 pmRNSDirector/PDMR Shareholding
25th Nov 20252:26 pmRNSHolding(s) in Company
18th Nov 20254:27 pmRNSDirector/PDMR Shareholding
14th Nov 20253:00 pmRNSPublication of a Prospectus
14th Nov 20252:44 pmRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.